| Ol (lots) | Call Price | Strike Price | Put Price | Ol (lots) |
|---|---|---|---|---|
| 1,5500% | ₹122.2 0% | 800 | ₹0.2 -20% | 32,550-4.54% |
| 2,3250% | ₹178.45 0% | 820 | ₹0.85 -5.55% | 5,4250% |
| - | - | 840 | ₹0.2 -50% | 18,6000% |
| 7750% | ₹131 0% | 850 | ₹0.4 0% | 42,625-1.78% |
| - | - | 860 | ₹0.65 0% | 31,7750% |
| 2,3250% | ₹129.2 0% | 870 | ₹0.6 0% | 22,4750% |
| 3,1000% | ₹119.3 0% | 880 | ₹1.5 0% | 51,1500% |
| 7750% | ₹44.4 0% | 890 | ₹0.7 -56.25% | 38,750-3.84% |
| 99,975-0.76% | ₹101 10.38% | 900 | ₹1.4 -33.33% | 1,58,875-4.65% |
| 26,3500% | ₹90 0% | 910 | ₹1.95 -15.21% | 47,275-7.57% |
| 43,4000% | ₹78.9 0% | 920 | ₹2.85 -21.91% | 1,86,775-2.42% |
| 67,425-2.24% | ₹66.5 -1.48% | 930 | ₹3.95 -17.7% | 1,16,250-8.53% |
| 55,025-2.73% | ₹56.35 -4% | 940 | ₹5.6 -12.5% | 1,58,100-5.55% |
| 1,68,950-2.24% | ₹49.1 -2.96% | 950 | ₹7.2 -15.29% | 1,12,375-13.69% |
| 86,025-3.47% | ₹41.6 -2.34% | 960 | ₹9.75 -13.71% | 1,61,200-6.30% |
| 83,700-4.42% | ₹34.45 -2.54% | 970 | ₹13 -10.95% | 1,13,150-6.41% |
| 1,50,350-16.73% | ₹29.2 -2.66% | 980 | ₹16.2 -12.19% | 2,08,475-7.24% |
| 1,55,775-14.83% | ₹23.2 -4.72% | 990 | ₹21 -8.09% | 1,33,300-11.34% |
| 7,19,975-1.38% | ₹18.7 -5.55% | 1,000 | ₹25.85 -8.49% | 2,28,625-5.14% |
| 1,74,37515.97% | ₹14.5 -5.84% | 1,010 | ₹32.5 -5.52% | 2,14,6752.21% |
| 1,43,375-5.61% | ₹11.15 -10.08% | 1,020 | ₹42.85 0% | 34,1000% |
| 1,02,3001.53% | ₹8.2 -14.58% | 1,030 | ₹51 1.19% | 10,8500% |
| 2,35,60016.92% | ₹6.2 -16.21% | 1,040 | - | - |
| 1,87,550-3.58% | ₹4.45 -21.23% | 1,050 | ₹60 5.91% | 20,1500% |
| 4,79,72524.04% | ₹3.6 -17.24% | 1,060 | - | - |
| 66,650-5.49% | ₹2.45 -26.86% | 1,070 | ₹89.05 0% | 3,1000% |
| 2,01,500-12.45% | ₹2.2 -13.72% | 1,080 | ₹82.9 0% | 3,8750% |
| 5,61,87510.68% | ₹1.4 -20% | 1,100 | ₹104 0% | 1,5500% |
Fortis will take charge of the entire operational and financial aspects. Hence, consolidating the hospital's performance within its network.
Operating performance remained strong with EBITDA rising 43% year-on-year to ₹490.4 crore. The EBITDA margin expanded to 22.6%, from 18.4% a year ago.
The tax demand will not affect the company’s financials or operations, it said in a regulatory filing.
Here are some of the stocks that may see significant price movement today: UltraTech Cement, Jio Financial, Avenue Supermarts, etc.
EBITDA grew 32.1% YoY at ₹375.2 crore v/s ₹284 crore, a period to period, as was the expansion of EBITDA margin at 19.5% versus 16.9% Q3 FY24.
The deal worth ₹429.37 crore involves acquiring 5,970,149 equity shares at an agreed price of ₹719.2 per share through a shareholders' agreement.
Revenue from operations saw a notable growth of 12.3%, reaching ₹1,988.4 Crore, compared to ₹1,770 Crore YoY.
Jacob Ballas and International Finance Corporation (IFC), who together with Resurgence PE own approximately 34% of the diagnostics company.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
